STL Volume 15 Number 8

3 POSTS 0 COMMENTS
Purchase PDF for $2.79Update on Drugs and Drug News: September 2010
Update on drugs, approval dates, and comments. Velaglucerase alfa (VPRIV®) and Health Canada labelling changes for isopropyl myristate 50% rinse (Resultz®, Nycomed) to include the treatment of lice in children =2 years of age are covered.
The Management of Chronic Pruritus in the Elderly
The elderly in North America is the fastest growing segment of the population and their most common skin complaint is pruritus. This article outlines the therapeutic challenges with this population.
Nanodermatology: A Bright Glimpse Just Beyond the Horizon – Part I
Nanotechnology is a relatively new branch of engineering that is making rapid inroads in medicine and dermatology. This article summarizes some of the recent and anticipated advances in nanotechnology for dermatology. In part II, the author addresses the chief concerns of nanotechnology.